Localized scleroderma [morphea]
ICD-10 L94.0 is a billable code used to indicate a diagnosis of localized scleroderma [morphea].
Localized scleroderma, also known as morphea, is a chronic dermatological condition characterized by the localized thickening and hardening of the skin due to collagen deposition. It primarily affects the dermis and subcutaneous tissue, leading to plaques that can vary in size and color, often presenting as ivory or purple patches. The condition may be asymptomatic or associated with mild pruritus. Morphea can occur in various forms, including plaque morphea, generalized morphea, and linear scleroderma, each with distinct clinical presentations. Disease progression can lead to skin atrophy, pigment changes, and in some cases, joint or muscle involvement. Diagnosis is primarily clinical, supported by skin biopsy when necessary to rule out other conditions. Diagnostic considerations include the exclusion of systemic sclerosis and other connective tissue diseases. Early recognition and management are crucial to prevent complications and improve patient outcomes.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L94.0 specifically covers localized scleroderma (morphea), which includes various forms such as plaque morphea and linear scleroderma. It is characterized by localized skin changes and does not encompass systemic scleroderma.
L94.0 should be used when the clinical presentation is limited to localized skin involvement without systemic features. It is essential to differentiate it from generalized morphea (L94.1) and linear scleroderma (L94.2) based on the extent and pattern of skin changes.
Documentation should include a thorough clinical examination, description of skin lesions, and any relevant biopsy results. Notes should detail the extent of skin involvement and any associated symptoms to support the diagnosis.
